Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Hideki Uedono"'
Autor:
Katsuhito Mori, Tsutomu Inoue, Yuri Machiba, Hideki Uedono, Shinya Nakatani, Masahiro Ishikawa, Satsuki Taniuchi, Yutaka Katayama, Akira Yamamoto, Naoki Kobayashi, Eito Kozawa, Taro Shimono, Yukio Miki, Hirokazu Okada, Masanori Emoto
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundRecent clinical studies suggest protective effects of SGLT2 inhibitors on kidney disease outcome. Chronic hypoxia has a critical role in kidney disease development, thus we speculated that canagliflozin, an SGLT2 inhibitor, can improve kidn
Externí odkaz:
https://doaj.org/article/4e751c838da845bab3424f6068999ade
Autor:
Hideki Uedono, Katsuhito Mori, Shinya Nakatani, Kohei Watanabe, Rino Nakaya, Fumiyuki Morioka, Kazuma Sone, Chie Ono, Junko Hotta, Akihiro Tsuda, Naoya Morisada, Toshiyuki Seto, Kandai Nozu, Masanori Emoto
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 14, Iss 1, Pp 1-9 (2024)
Introduction: Alport syndrome (AS) is a hereditary, progressive kidney disease characterized by structural abnormalities and dysfunction of the glomerular basement membrane (GBM). AS is classified as X-linked, autosomal, and digenic. The number of ca
Externí odkaz:
https://doaj.org/article/f5a7078a2df046aa9981ea1649ec053c
Autor:
Shinya Nakatani, Eiji Ishimura, Takayo Murase, Takashi Nakamura, Ayumi Nakatani, Norikazu Toi, Kozo Nishide, Hideki Uedono, Akihiro Tsuda, Masafumi Kurajoh, Shinsuke Yamada, Katsuhito Mori, Masaaki Inaba, Masanori Emoto
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-9 (2021)
Introduction: Xanthine oxidoreductase (XOR) activity plays an important role as a pivotal source of reactive oxygen species, which is associated with cardiovascular disease (CVD) events. Patients with CKD have increased risk of CVD events. In the pre
Externí odkaz:
https://doaj.org/article/882587d59e744151a580b1ae6b41f088
Autor:
Shinya Nakatani, Kozo Nishide, Senji Okuno, Eiji Ishimura, Daijiro Kabata, Fumiyuki Morioka, Yuri Machiba, Hideki Uedono, Akihiro Tsuda, Shigeichi Shoji, Masaaki Inaba, Katsuhito Mori, Tomoyuki Yamakawa, Masanori Emoto
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract A massively enlarged kidney can impact quality of life of autosomal dominant polycystic kidney disease (ADPKD) patients. A recent in vitro study demonstrated that an allosteric modulator of the calcium sensing receptor decreases adenosine-3
Externí odkaz:
https://doaj.org/article/4d7d233e64e54f819c340bec880d0e73
Autor:
Hideki Uedono, Katsuhito Mori, Akinobu Ochi, Shinya Nakatani, Yuya Miki, Akihiro Tsuda, Tomoaki Morioka, Yuki Nagata, Yasuo Imanishi, Tetsuo Shoji, Masaaki Inaba, Masanori Emoto
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Fetuin-A is an inhibitor of ectopic calcification that is expressed mainly in hepatocytes and is secreted into the circulation after posttranslational processing, including glycosylation and phosphorylation. The molecular weight (MW) of full
Externí odkaz:
https://doaj.org/article/03689133350140b5824577f32340636f
Autor:
Akihiro Tsuda, Eiji Ishimura, Yuri Machiba, Hideki Uedono, Shinya Nakatani, Katsuhito Mori, Junji Uchida, Masanori Emoto
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-13 (2020)
Background: Cr is secreted by the proximal tubules and thus Cr clearance (Ccr) can overestimate inulin clearance (Cin). However, in some cases, Ccr can even underestimate Cin. This suggests that Cr could be reabsorbed in the tubuli. We examined the c
Externí odkaz:
https://doaj.org/article/3bbf2d18e17a48cc9e52b243d7877bf4
Autor:
Shinya Nakatani, Eiji Ishimura, Yuri Machiba, Kenta Fujimoto, Hideki Uedono, Akihiro Tsuda, Katsuhito Mori, Masanori Emoto, Masaaki Inaba
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 10, Iss 1, Pp 9-17 (2020)
Tolvaptan, a vasopressin V2 receptor antagonist, was initially approved in Japan for treatment of autosomal dominant polycystic kidney disease (ADPKD). Recently, a retrospective study showed that the effect of tolvaptan on kidney function could be su
Externí odkaz:
https://doaj.org/article/4dfdc5727e88458297af2366afb44e13
Autor:
Akihiro Tsuda, Eiji Ishimura, Hideki Uedono, Mari Yasumoto, Mitsuru Ichii, Shinya Nakatani, Katsuhito Mori, Junji Uchida, Masanori Emoto, Tatsuya Nakatani, Masaaki Inaba
Publikováno v:
Kidney & Blood Pressure Research, Vol 41, Iss 1, Pp 40-47 (2016)
Background/Aims: We have reported that the eGFR overestimates renal function when glycemic control is poor. It has been reported that eGFR calculated by serum creatinine underestimates GFR in living kidney donors. We compared the utility of the eGFR
Externí odkaz:
https://doaj.org/article/5211019a6e794c94b1ae4eef5ddb8e68
Autor:
Shinya Nakatani, Katsuhito Mori, Mika Sonoda, Kozo Nishide, Hideki Uedono, Akihiro Tsuda, Masanori Emoto, Tetsuo Shoji
Publikováno v:
Biomedicines, Vol 8, Iss 9, p 337 (2020)
Zinc inhibits vascular calcification in vivo and in vitro. Patients with type 2 diabetes mellitus show hypozincemia and are at an elevated risk of cardiovascular events. Recently, an in vitro test (T50-test) was developed for determination of serum c
Externí odkaz:
https://doaj.org/article/a1cac3711a8042d7a663319699f60d7f
Autor:
Hideki Uedono, Akihiro Tsuda, Eiji Ishimura, Mari Yasumoto, Mitsuru Ichii, Akinobu Ochi, Yoshiteru Ohno, Shinya Nakatani, Katsuhito Mori, Junji Uchida, Tatsuya Nakatani, Masaaki Inaba
Publikováno v:
Kidney & Blood Pressure Research, Vol 40, Iss 3, Pp 315-322 (2015)
Background/Aims: Hyperuricemia has been reported to affect renal hemodynamics in rat models. We evaluate the relationship between serum uric acid and intrarenal hemodynamic parameters in humans, utilizing the plasma clearance of para-aminohippurate (
Externí odkaz:
https://doaj.org/article/00f7e4a4cdd04121bd5234e665af0f8d